Genetical Evaluation of resistance to amantadine in H9N2 Avian influenza virus in Iran between 1998 to 2009

Subject Areas : Veterinary Clinical Pathology

Received: 2011-05-29 Accepted : 2011-10-15 Published : 2012-02-20

Keywords: Amantadine resistance, Avian influenza A virus, H9N2 subtype, Matrix protein M2,

Abstract :

Spread of an epidemic of avian influenza in 1998 in Iran was the cause of many deaths on farms. Research shows that made the emergence of this epidemic of avian influenza virus subtype H9N2. Anti-influenza drugs amantadine and rimantadine (Adamantane) were used for the treatment and prevention of infections caused by influenza A virus, but the use of these medications has been limited in recent years with increased resistance in the world. In a comparative study between the years 1998 to 2009 in Iran, to evaluate resistance to amantadine, the avian influenza A virus of subtype H9N2, we focused our research on the genetic structure of viruses, amantadine where most of their leaves left on the channel protein M2. Two groups of avian influenza A virus H9N2 subtype, were isolated in eggs with embryos, including five samples of the virus to two periods (1998-2006 and 2007-2009), then were the polymerase chain reaction tests using reverse transcription (RT-PCR) and electrophoresis on agarose gel and were sent for sequencing. The M2 sequence analysis displayed in different separate parts of this sequence as to consensus sequence that was amino acid changes together. And all of resistant isolates contained the point mutations (Ser to Asn) S31N at position 31 that could confer resistance to amantadine. The study took place, to determine the effectiveness of awareness of avian influenza viruses to amantadine, was reported, amantadine resistance in H9N2 subtype avian influenza viruses in the years 2007 and 2009 in Iran. Therefore, it is recommended to avoid the arbitrary use of amantadine to treat and prevent infections from avian influenza viruses of H9N2 subtype in the farms. Furthermore, it seems practical tests of the drug influence invivo, can ensure effective use of the drug.

References:

1. Abed, Y., N. Goyette, and G. Boivin. 2005. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrobial agents and chemotherapy 49:556.


2. Bai, G. R., M. Chittaganpitch, Y. Kanai, Y. G. Li, W. Auwanit, K. Ikuta, and P. Sawanpanyalert. 2009. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand. Biochem Biophys Res Commun 390:897-901.


3. Bauera, M. S. R. Z. K., A. Krumbholza, and C. S. J. S. P. Wutzlera. 2006. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001. Intervirology 49:286-293.


4. CDC. Centers for Diasease Control and prevention. Avian Influenza A Virus Infections of Humans. (Accessed May 23, 2008 , at http://www.cdc.gov/flu/avian/gen-info/avian-flu-humans.htm).


5. CDC. Centers for Disease Control and Prevention. Key Facts About Avian Influenza (Bird Flu) and Highly Pathogenic Avian Influenza A (H5N1) Virus. (Accessed November 21, 2010, at http://www.cdc.gov/flu/avian/gen-info/facts.htm).


6. CDC. Centers for Disease Control and Prevention. Updated CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009 – April 10, 2010. (Accessed May 14, 2010, at http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm).


7. Cha, R. S., H. Zarbl, P. Keohavong, and W. G. Thilly. 1992. Mismatch amplification mutation assay (MAMA): application to the cH-ras gene. Genome Research 2:14.


8. Furuse, Y., A. Suzuki, and H. Oshitani. 2009. Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance. Antimicrobial agents and chemotherapy 53:4457.


9. Hata, M., M. Tsuzuki, Y. Goto, N. Kumagai, M. Harada, M. Hashimoto, S. Tanaka, K. Sakae, T. Kimura, H. Minagawa, and Y. Miyazaki. 2007. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR. Jpn J Infect Dis 60:202-204.


10. Hayden, F. G., and A. T. Pavia. 2006. Antiviral management of seasonal and pandemic influenza. Journal of Infectious Diseases 194:S119.


11. Hu, J., T. Asbury, S. Achuthan, C. Li, R. Bertram, J. R. Quine, R. Fu, and T. A. Cross. 2007. Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from influenza A virus. Biophysical journal 92:4335-4343.


12. Huang, Y., B. Hu, X. Wen, S. Cao, D. Xu, X. Zhang, and M. I. Khan. 2009. Evolution analysis of the matrix (M) protein genes of 17 H9N2 chicken influenza viruses isolated in northern China during 1998-2008. Virus Genes 38:398-403.


13. Kwon, H. J., S. H. Cho, Y. J. Ahn, J. H. Kim, H. S. Yoo, and S. J. Kim. 2009. Characterizationof a Chicken Embryo-Adapted H9N2 Subtype Avian Influenza Virus. Open Veterinary Science Journal 3:9-16.


14. Marandi, M. V., and M. H. B. Fard. 2002. Isolation of H9N2 subtype of avian influenza viruses during an outbreak in chickens in Iran. Iranian Biomedical Journal 6:13-17.


15. Nili, H., and K. Asasi. 2003. Avian influenza (H9N2) outbreak in Iran. Avian diseases 47:828-831.


16. Pielak, R. M., J. R. Schnell, and J. J. Chou. 2009. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proceedings of the NationalAcademy of Sciences 106:7379.


17. Pourbakhsh, S., M. Khodashenas, M. Kianizadeh, and H. Goodarzi. 2000. Isolation and identification of avian influenza virus H9N2 subtype. ARCHIVES OF RAZI INSTITUTE 51:27-38.


18. Schnell, J. R., and J. J. Chou. 2008. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451:591-595.


19. Suzuki, Y., R. Saito, H. Zaraket, C. Dapat, I. Caperig-Dapat, and H. Suzuki. 2010. Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method. J Clin Microbiol 48:57-63.


20. Wright, P. F., G. Neumann, Y. Kawaoka, D. Knipe, and P. Howley. 2007. Orthomyxoviridae. Fields Virology 5th edition. Philadelphia: Lippincott Williams & Wilkins:1691–1740.


21. Yavarian, J., T. M. Azad, X. Zheng, V. Gregory, Y. P. Lin, and A. Hay. 2010. Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran. Antiviral Res 88:193-196.


22. Yavarian, J., T. Mokhtari Azad, N. Z. Shafiei Jandaghi, and R. Nategh. 2009. Amantadine-resistant influenza A (H3N2) viruses in Iran. Acta Virol 53:135-138.